Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.45 |
| ▸ | KDM1A | O60341 | 1/20 | 0.38 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.38 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | MAP1LC3B | Q9GZQ8 | 6/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22111797 | 0.88 | MAP1LC3B (0.40) | KDM1ACARM1PRMT6CYP2C19MAP1LC3B | |
| SCHEMBL22111791 | 0.87 | LMNA (0.39) | SLC18A3MEN1KMT2AALDH1A1HTT | |
| SCHEMBL21821591 | 0.83 | SLC18A3 (0.50) | SLC18A3KDM1ACARM1PRMT6CYP2C19 | |
| SCHEMBL22111645 | 0.80 | ALDH1A1 (0.36) | CYP2C19MAP1LC3BKMT2AALDH1A1TSHR | |
| SCHEMBL22111781 | 0.78 | MAPK1 (0.40) | KMT2AALDH1A1 | |
| SCHEMBL22111856 | 0.77 | CCR2 (0.33) | MEN1KMT2A | |
| SCHEMBL22111786 | 0.77 | JAK1 (0.41) | — | |
| SCHEMBL21821572 | 0.75 | SLC18A3 (0.41) | SLC18A3CARM1PRMT6CYP2C19MAP1LC3B | |
| SCHEMBL21821781 | 0.73 | ALDH1A1 (0.38) | SLC18A3MAP1LC3BMEN1KMT2AALDH1A1 | |
| SCHEMBL26524902 | 0.73 | SLC18A3 (0.40) | SLC18A3KDM1ACYP2C19MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11319303-B2 | Compound used as autophagy regulator, and preparation method therefor and uses thereof | Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) | 2022-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11319303-B2 | Compound used as autophagy regulator, and preparation method therefor and uses thereof | ATG7, SQSTM1, BECN1 | SLC18A3 2277/4885KDM1A 3424/4885CARM1 2361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.